Levalbuterol Solution
Product Images NDC 67296-2304

Product Visual Gallery

This gallery contains 19 technical images submitted to the FDA as part of the official labeling for Levalbuterol (NDC 67296-2304). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chem Structure (Levalbuterol Inhalation Solution 1)

Chemical structure of Levalbuterol Hydrochloride, showing the molecular formula with functional groups and hydrochloride component.*

FDA Label Image

Figure D (Levalbuterol Inhalation Solution 10)

An instructional illustration showing a hand inserting a vial into a reservoir component. The parts are labeled "VIAL" for the small container being held, and "RESERVOIR" for the larger component receiving the vial, indicating steps for assembling or preparing a device related to Levalbuterol inhalation solution.*

FDA Label Image

Figure E1 (Levalbuterol Inhalation Solution 11)

An instructional diagram of a respiratory inhalation device showing the mouthpiece attachment and the reservoir component. The diagram highlights the parts labeled as 'Mouthpiece' and 'Reservoir,' illustrating their connection.*

FDA Label Image

Figure E2 (Levalbuterol Inhalation Solution 12)

Illustration showing a face mask connected to a reservoir, likely representing components used for respiratory inhalation delivery of a drug solution.*

FDA Label Image

Figure F (Levalbuterol Inhalation Solution 13)

Illustration showing a segment of a medical device with labeled components: a dial marked 'COMPRESSOR' and connected tubing labeled 'NEBULIZER TUBING'. This diagram highlights parts of a nebulizer setup used for respiratory inhalation therapy.*

FDA Label Image

Figure G1 (Levalbuterol Inhalation Solution 14)

An instructional illustration showing the proper positioning of a respiratory inhalation device. The image labels the mouthpiece and reservoir of the device, depicting a person holding the reservoir and placing the mouthpiece into their mouth for inhalation.*

FDA Label Image

Figure G2 (Levalbuterol Inhalation Solution 15)

An instructional illustration showing a respiratory inhalation setup. It depicts a face mask labeled 'FACE MASK' connected to a reservoir labeled 'RESERVOIR,' intended for delivering inhalation solution medication.*

FDA Label Image

Logo (Levalbuterol Inhalation Solution 16)

FDA Label Image

Carton (Levalbuterol Inhalation Solution 17)

Packaging label for Levalbuterol Inhalation Solution USP 0.31 mg/3 mL, a respiratory inhalation solution. The label displays the proprietary and generic names, strength, dosage form, and manufacturer Redpharm Drug. It includes barcodes, NDC numbers, usage and storage instructions, and medication warnings. The label is formatted as a flat, unfolded box.*

FDA Label Image

Carton (Levalbuterol Inhalation Solution 18)

Packaging label for Levalbuterol Inhalation Solution, USP 0.63 mg/3 mL by Redpharm Drug. The label displays the product name, strength, dosage form (solution for inhalation), and directions indicating it is for respiratory use only. The product is prescription only (Rx). The label includes manufacturer information and barcode details on the carton.*

FDA Label Image

Carton (Levalbuterol Inhalation Solution 19)

Packaging label for Levalbuterol Inhalation Solution USP 1.25 mg (0.042%) per 3 mL unit dose, a respiratory inhalation solution. The label includes instructions, warnings, barcodes, and the Redpharm Drug labeler information. The carton is unfolded, showing all sides with dosage, storage instructions, and manufacturer details.*

FDA Label Image

Figure 1 (Levalbuterol Inhalation Solution 2)

A line graph depicting the mean change in FEV1 (%) over time (hours) for four treatment groups: Lev 1.25 mg, Lev 0.63 mg, Rac 2.5 mg, and placebo (PB0). The x-axis represents time from 0 to 8 hours, and the y-axis shows mean change in FEV1 percentage. Each treatment group shows a rapid initial increase, peaking around 1 hour, followed by a gradual decline. A dashed horizontal line marks a 15% change in FEV1.*

FDA Label Image

Figure 2 (Levalbuterol Inhalation Solution 3)

A line graph depicting mean change in FEV1 (%) over time (hours) for four groups: Lev 1.25 mg, Lev 0.63 mg, Rac 2.5 mg, and placebo (PBO). The x-axis shows time in hours from 0 to 8, and the y-axis shows mean change in FEV1 percentage. Each group is represented by different symbols and lines showing FEV1 changes peaking between 0 to 1 hour and decreasing over 8 hours.*

FDA Label Image

Figure 3 (Levalbuterol Inhalation Solution 4)

A line graph displaying the mean change in FEV1 (%) over time in hours for different treatments involving Levalbuterol and Racemic albuterol compared to placebo. The graph includes data points for Levalbuterol at 0.63 mg and 0.31 mg, Racemic albuterol at 2.5 mg and 1.25 mg, and a placebo group, with a horizontal dashed line indicating a 15% change threshold.*

FDA Label Image

Figure 4 (Levalbuterol Inhalation Solution 5)

A line graph showing mean change in FEV1 (%) over time (hours) for different treatments including Levalbuterol at 0.63 mg and 0.31 mg, Rac (racemic mixture) at 2.5 and 1.25 doses, and placebo. The graph plots changes from 0 to 4 hours after administration, with multiple markers and a horizontal reference line at 15%.*

FDA Label Image

Logo (Levalbuterol Inhalation Solution 6)

FDA Label Image

Figure A (Levalbuterol Inhalation Solution 7)

An instructional diagram illustrating the twist-off tab portion of a vial. It shows the vial's top with arrows indicating the direction to twist off the tabs on both sides, and a shaded area marking the twist-off tab portion of the vial.*

FDA Label Image

Figure B (Levalbuterol Inhalation Solution 8)

Illustration showing the top part of a flexible pouch with an arrow pointing to the seam and the text 'TEAR AT SEAM,' indicating where to open the pouch.*

FDA Label Image

Figure C (Levalbuterol Inhalation Solution 9)

An instructional illustration showing a hand holding and twisting the cap off a small vial or ampule, likely demonstrating how to open the vial containing the inhalation solution.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.